Covalent conjugates of granulin-epithelial precursor-siRNA with arginine-rich peptide for improved stability and intracellular delivery in hepatoma cells
Conclusion: These results provide insights into the importance of chemical modification of unstable genetic therapeutics for HCC treatment. Conjugation of PEGylated GEP siRNA with ARP may be a potential HCC therapeutic agent.
Source: Molecular and Cellular Toxicology - Category: Cytology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemistry | Cytology | Epithelial Cancer | Genetics | Hepatocellular Carcinoma | Liver Cancer | Polyethylene Glycol | Toxicology